Shenouda Maged Insider Trades

Insider Trading History

Track insider trading activity for Shenouda Maged. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $5.06M 800,000 shares
Last Trade
Dec 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$48.1k 11,665 shares
$4.12
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $5.24M 828,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.36M 828,000 shares
$4.06
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $4.99M 788,335 shares
Last Trade
Nov 05, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.26M 500,000 shares
$2.51
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $3.8M 600,000 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$402k 600,000 shares
$0.67
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $1.83M 288,335 shares
Last Trade
May 20, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$35.8k 60,000 shares
$0.60
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $1.45M 228,335 shares
Last Trade
May 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$44.1k 90,000 shares
$0.49
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $876k 138,335 shares
Last Trade
May 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22k 50,000 shares
$0.44
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $559k 88,335 shares
Last Trade
Sep 11, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$71.2k 24,120 shares
$2.95
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $406k 64,215 shares
Last Trade
Sep 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$57.7k 21,118 shares
$2.73
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $273k 43,097 shares
Last Trade
Sep 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.9k 8,194 shares
$2.55
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $865k 136,714 shares
Last Trade
May 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 54,624 shares
$3.05
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $520k 82,090 shares
Last Trade
May 24, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$167k 54,624 shares
$3.05
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $221k 34,903 shares
Last Trade
Jan 31, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.9k 6,875 shares
$4.06
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $177k 28,028 shares
Last Trade
Jan 30, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.4k 15,000 shares
$3.89
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $82.5k 13,028 shares
Last Trade
Jan 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$39.4k 10,800 shares
$3.65
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $520k 82,090 shares
Last Trade
Dec 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 82,090 shares
$2.48
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $3.24M 512,560 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$902k 317,643 shares
$2.84
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $1.23M 194,917 shares
Last Trade
Dec 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$657k 194,917 shares
$3.37
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
CFO
Holding Value $0 0 shares
Last Trade
Dec 16, 2022 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$674k 200,000 shares
$3.37
$6.33
Relmada Therapeutics
Relmada Therapeutics RLMD
Chief Financial Officer
Holding Value $1.27M 200,000 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.84M 200,000 shares
$19.21
$6.33

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up